MLchartDataset catalogue

autologous cervical cancer-specific engineered immune effector cells

Term · Oncology and biomedicine · MLC-T-ONC-011569

A preparation of autologous immune effector cells genetically modified to target a not yet disclosed cervical cancer-specific tumor-associated antigen (TAA), with potential immunomodulating and antineoplastic activities. After isolation, transduction, expansion in culture, and reintroduction into the patient, the autologous cervical cancer-specific engineered immune effector (CC-EIE) cells bind to and induce selective toxicity in tumor cells expressing the TAA.

Table 1. Record
IdentifierMLC-T-ONC-011569
FieldOncology and biomedicine
Synonymsautologous CC-EIEs; autologous CC-EIE cells
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011569",
  "term": "autologous cervical cancer-specific engineered immune effector cells",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of autologous immune effector cells genetically modified to target a not yet disclosed cervical cancer-specific tumor-associated antigen (TAA), with potential immunomodulating and antineoplastic activities. After isolation, transduction, expansion in culture, and reintroduction into the patient, the autologous cervical cancer-specific engineered immune effector (CC-EIE) cells bind to and induce selective toxicity in tumor cells expressing the TAA.",
  "synonyms": [
    "autologous CC-EIEs",
    "autologous CC-EIE cells"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-cervical-cancer-specific-engineered-immune-effector-cells/"
}

Record 2,903 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.